Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d4424bcc6bce434e2eef0f50134c45a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8aebc762914a0aac859dd4bc8b558617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d04c7142d85d086f9b461175b2e7962 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_386b2deabf133cecfa12a77b4efbdceb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daaacf2faeca68f22e7ca2d8167e1d9a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
filingDate |
2008-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5b306abe3f0a992d32c6feedfe77c5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf054263a87c2c4a02646ba98fde827e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e755538972b279e5e6f6d953466f17b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4305fd91634818c1e67aee96d63a495f |
publicationDate |
2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008097539-A2 |
titleOfInvention |
Multi-modal absorption, medicine-delivery lozenge, and use thereof |
abstract |
A multi-modal absorption, medicine-delivery lozenge is provided. The lozenge includes a lozenge base, a medicinal active ingredient including an antihistamine convertible between ionized and non-ionized states, and a buffer present in an effective amount for establishing an adjusted pH in a solvent having a pH comparable to that of saliva which is characterized by a simultaneous presence of a first pharmacologically effective dose of the non-ionized form of the medicinal active ingredient, and a second pharmacologically effective dose of the ionized form of the medicinal active ingredient. |
priorityDate |
2007-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |